How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease

How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease

Background Acute rheumatic fever (ARF) and rheumatic heart disease cause substantial burdens worldwide. Long‐term antibiotic secondary prophylaxis is used to prevent disease progression, but evidence for benefits of different adherence levels is limited. Using data from northern Australia, we identi...

Full description

Bibliographic Details
Main Authors: Jessica Langloh de Dassel, Nick de Klerk, Jonathan Rhys Carapetis, Anna P. Ralph
Format: Article
Language:English
Published: Wiley 2018-12-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute rheumatic fever
adherence
Australian Indigenous
rheumatic heart disease
secondary prophylaxis
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.010223

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.010223

Similar Items